We are live on ! Find out more
Fiera Capital (Canada)

Fiera Capital (Canada) Portfolio holdings

AUM $29.2B
1-Year Est. Return 20.16%
This Fund
S&P 500
This Quarter Est. Return
-5.12%
1 Year Est. Return
+20.16%
3 Year Est. Return
+63.52%
5 Year Est. Return
+88.28%
10 Year Est. Return
+410.23%
AUM
$27.9B
AUM Growth
-$5.85B
Cap. Flow
-$39.5B
Cap. Flow %
-141.74%
Top 10 Hldgs %
40.08%
Holding
599
New
23
Increased
121
Reduced
323
Closed
59

Sector Composition

Rank Sector Weight
1 Financials 22.2%
2 Technology 17.7%
3 Healthcare 15.57%
4 Industrials 13.72%
5 Consumer Discretionary 11.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDDY icon
76
GoDaddy
GDDY
$11.5B
$43.7M 0.16%
654,972
-11,475
-2% -$864K
NDSN icon
77
Nordson
NDSN
$17.3B
$42.7M 0.15%
213,546
-4,535
-2% -$1.02M
OTEX icon
78
Open Text
OTEX
$5.92B
$42.5M 0.15%
1,628,664
-3,742,860
-70% -$132M
NSP icon
79
Insperity
NSP
$2.01B
$40.9M 0.15%
437,385
-9,058
-2% -$973K
FSV icon
80
FirstService
FSV
$6.32B
$40.6M 0.15%
362,674
-21,506
-6% -$2.75M
JKHY icon
81
Jack Henry & Associates
JKHY
$11B
$40.6M 0.15%
234,939
-241
-0.1% -$47.3K
RRX icon
82
Regal Rexnord
RRX
$12B
$39.6M 0.14%
314,098
-4,174
-1% -$561K
NYT icon
83
New York Times
NYT
$10.3B
$38.6M 0.14%
1,458,369
-51,335
-3% -$1.57M
FOLD
84
DELISTED
Amicus Therapeutics
FOLD
$38.1M 0.14%
4,016,555
-66,317
-2% -$739K
NBIX icon
85
Neurocrine Biosciences
NBIX
$16.7B
$37.5M 0.13%
375,087
-3,719
-1% -$377K
ADSK icon
86
Autodesk
ADSK
$52.4B
$37.5M 0.13%
200,591
+12,680
+7% +$2.56M
MRTX
87
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$37.2M 0.13%
533,350
-6,735
-1% -$498K
EXEL icon
88
Exelixis
EXEL
$13.1B
$37.2M 0.13%
2,598,573
-90,975
-3% -$1.76M
BMRN icon
89
BioMarin Pharmaceuticals
BMRN
$12.2B
$36.9M 0.13%
461,362
-4,192
-0.9% -$373K
DLB icon
90
Dolby
DLB
$5.75B
$35.4M 0.13%
590,945
-13,209
-2% -$982K
AOS icon
91
A.O. Smith
AOS
$8.67B
$35.3M 0.13%
796,476
-18,702
-2% -$1.07M
AON icon
92
Aon
AON
$76B
$35.1M 0.13%
130,971
-2,294
-2% -$648K
RACE icon
93
Ferrari
RACE
$72.2B
$34.7M 0.12%
187,602
+12,003
+7% +$2.39M
VEEV icon
94
Veeva Systems
VEEV
$37B
$33.9M 0.12%
205,384
+13,111
+7% +$2.62M
ARWR icon
95
Arrowhead Research
ARWR
$12.3B
$33.2M 0.12%
1,094,692
-24,371
-2% -$984K
HUBS icon
96
HubSpot
HUBS
$10.2B
$33.1M 0.12%
130,373
+43,408
+50% +$13.8M
ACN icon
97
Accenture
ACN
$106B
$32.7M 0.12%
127,044
+3,479
+3% +$1.01M
URI icon
98
United Rentals
URI
$73B
$32.6M 0.12%
128,697
-3,815
-3% -$1.11M
EW icon
99
Edwards Lifesciences
EW
$51.6B
$32.3M 0.12%
390,487
+24,386
+7% +$2.35M
J icon
100
Jacobs Solutions
J
$17.1B
$32.2M 0.12%
383,957
-15,385
-4% -$1.59M

Similar funds

Fiera Capital (Canada)'s Q3 2022 Portfolio in Review

As of Q3 2022, Fiera Capital (Canada) held 599 positions worth $27.9B, down 17% from $33.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fiera Capital (Canada) withdrew a net $39.5B in Q3 2022, closing 59 positions and reducing 323 holdings. Its most notable exit was Zentalis Pharmaceuticals, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Fiera Capital (Canada) opened a new position in Tyler Technologies worth $45.5M.

  • Fiera Capital (Canada)'s largest Q3 2022 buy was Tyler Technologies: 139,291 shares worth $45.5M.
  • Fiera Capital (Canada) added most to Lattice Semiconductor in Q3 2022, an estimated $36.4M increase.
  • Fiera Capital (Canada)'s biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $37.7B.
  • Fiera Capital (Canada) fully exited Zentalis Pharmaceuticals in Q3 2022, selling an estimated $10.2M.
  • Fiera Capital (Canada)'s ten largest holdings make up 40% of its $27.9B portfolio in Q3 2022.
  • Fiera Capital (Canada) opened 23 new positions and closed 59 in Q3 2022.
  • Fiera Capital (Canada)'s portfolio value fell 17% quarter-over-quarter to $27.9B.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2022, filed 3 Nov 2022.